EOSINOPHIL PEROXIDASE AND THE ORIGINS OF ASTHMA
EOSINOPHIL PEROXIDASE AND THE ORIGINS OF ASTHMA
批准号:
6056576
负责人:
Stanley L Hazen
金额:
$25.38万
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-09-30 至 2002-08-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION
Eosinophils play an essential role in vivo, destroying pathogenic
microorganisms, parasites and tumor cells. To perform these functions they
have evolved enzymatic mechanisms to generate an arsenal of reactive oxidant
species; however, their potent oxidants also have great potential to harm
healthy tissue. Oxidative products of eosinophil activation are implicated
in the genesis of tissue injury in asthma. Eosinophil peroxidase (EPO), an
abundant heme protein secreted during eosinophil activation, amplifies the
oxidizing potential of hydrogen peroxide to generate potent cytotoxic
oxidants. Reactive oxidant species generated by EPO in model systems
reproduce the pathophysiologic features of asthma. Although substantial
evidence implicates EPO-dependent oxidative damage in the pathogenesis of
asthma, direct demonstration of the oxidation pathways which are operational
in vivo has yet to be established.
Two pathways have been identified for EPO-dependent oxidative damage of
cellular proteins and lipids which might contribute to the origins of
cellular injury in the inflammatory response in asthma: bromination and
nitration. EPO is the only known human enzyme which selectively generates
reactive brominating species under physiologic concentrations of halides;
identification of brominated products in vivo can thus serve as "molecular
fingerprints" identifying sites of EPO-catalyzed oxidative tissue damage.
Reactive nitrogen species have been implicated in the genesis of cellular
injury in a host of inflammatory disorders, yet neither their production by
eosinophils nor their role in oxidative damage during asthma are
established. The overall goals of this proposal are to test the hypothesis
that eosinophil peroxidase catalyzes oxidative tissue damage in vivo and
contributes to the onset of cellular injury in asthma.
The specific aims are: 1) to determine the role of eosinophil peroxidase in
oxidative damage of proteins in individuals with asthma; 2) to investigate
the biochemical pathways by which eosinophils generate reactive nitrogen
species; and 3) to characterize a family of brominated oxysterols
synthesized by eosinophil peroxidase and to examine their cytotoxic
properties.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Gut Microbiota and Cardiometabolic Diseases
-
批准号:10004722
-
项目类别:
-
资助金额:$242.39万
-
财政年份:2019
-
负责人:Stanley L Hazen
-
依托单位:
Gut Microbiota and Cardiometabolic Diseases
-
批准号:9790523
-
项目类别:
-
资助金额:$244.53万
-
财政年份:2019
-
负责人:Stanley L Hazen
-
依托单位:
Project 1: Discovery of gut microbiota dependent pathways contributing to cardiovascular disease in type 2 diabetes
-
批准号:10653050
-
项目类别:
-
资助金额:$52.33万
-
财政年份:2019
-
负责人:Stanley L Hazen
-
依托单位:
Gut Microbiota and Cardiometabolic Diseases
-
批准号:10653038
-
项目类别:
-
资助金额:$242.53万
-
财政年份:2019
-
负责人:Stanley L Hazen
-
依托单位:
Project 1: Discovery of gut microbiota dependent pathways contributing to cardiovascular disease in type 2 diabetes
-
批准号:10447069
-
项目类别:
-
资助金额:$52.33万
-
财政年份:2019
-
负责人:Stanley L Hazen
-
依托单位:
Gut Microbiota and Cardiometabolic Diseases
-
批准号:10206249
-
项目类别:
-
资助金额:$242.39万
-
财政年份:2019
-
负责人:Stanley L Hazen
-
依托单位:
Core A: Administrative/Clinical/Bioinformatics Core
-
批准号:10447065
-
项目类别:
-
资助金额:$21.74万
-
财政年份:2019
-
负责人:Stanley L Hazen
-
依托单位:
Core A: Administrative/Clinical/Bioinformatics Core
-
批准号:10206250
-
项目类别:
-
资助金额:$21.74万
-
财政年份:2019
-
负责人:Stanley L Hazen
-
依托单位:
Core A: Administrative/Clinical/Bioinformatics Core
-
批准号:10653039
-
项目类别:
-
资助金额:$21.74万
-
财政年份:2019
-
负责人:Stanley L Hazen
-
依托单位:
Gut Microbiota and Cardiometabolic Diseases
-
批准号:10447064
-
项目类别:
-
资助金额:$242.39万
-
财政年份:2019
-
负责人:Stanley L Hazen
-
依托单位:
Project 1: Discovery of gut microbiota dependent pathways contributing to cardiovascular disease in type 2 diabetes
-
批准号:10206254
-
项目类别:
-
资助金额:$52.33万
-
财政年份:2019
-
负责人:Stanley L Hazen
-
依托单位:
Dietary Choline, Gut Microbiota, and Susceptibility for Chronic Kidney Disease
-
批准号:9129779
-
项目类别:
-
资助金额:$68.96万
-
财政年份:2015
-
负责人:Stanley L Hazen
-
依托单位:
Dietary Choline, Gut Microbiota, and Susceptibility for Chronic Kidney Disease
-
批准号:9323444
-
项目类别:
-
资助金额:$68.96万
-
财政年份:2015
-
负责人:Stanley L Hazen
-
依托单位:
HDL Structure and its Function in Atherosclerosis
-
批准号:8724891
-
项目类别:
-
资助金额:$58.76万
-
财政年份:2013
-
负责人:Stanley L Hazen
-
依托单位:
Functional Cardio-Metabolomics
-
批准号:8805848
-
项目类别:
-
资助金额:$112.71万
-
财政年份:2012
-
负责人:Stanley L Hazen
-
依托单位:
Functional Cardio-Metabolomics
-
批准号:8617859
-
项目类别:
-
资助金额:$113.42万
-
财政年份:2012
-
负责人:Stanley L Hazen
-
依托单位:
Functional Cardio-Metabolomics
-
批准号:8456895
-
项目类别:
-
资助金额:$113.8万
-
财政年份:2012
-
负责人:Stanley L Hazen
-
依托单位:
Functional Cardio-Metabolomics
-
批准号:8287207
-
项目类别:
-
资助金额:$71.15万
-
财政年份:2012
-
负责人:Stanley L Hazen
-
依托单位:
Functional Cardio-Metabolomics
-
批准号:9020264
-
项目类别:
-
资助金额:$67.06万
-
财政年份:2012
-
负责人:Stanley L Hazen
-
依托单位:
CD36, A SCAVENGER RECEPTOR AND HDL, HIGH DENSITY LIPOPROTEIN
-
批准号:8361658
-
项目类别:
-
资助金额:$2.19万
-
财政年份:2011
-
负责人:Stanley L Hazen
-
依托单位:
海外基金